SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-139333
Filing Date
2020-12-23
Accepted
2020-12-23 21:30:38
Documents
1
Period of Report
2020-12-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm2039306-1_4.html 4  
1 FORM 4 tm2039306-1_4.xml 4 4150
  Complete submission text file 0001104659-20-139333.txt   5530
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Issuer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address
GRAY WILLIAM GARRETT (Reporting) CIK: 0001692961 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38128 | Film No.: 201414286